openPR Logo
Press release

Angiotensin Converting Enzyme Inhibitors Market With Top Key Players like Pfizer, AstraZeneca Pharmaceutical Company, Novartis AG, Daiichi Sankyo Company, Ltd. United Therapeutics Corporation, Sanofi S.A., Johnson & Johnson Services, Merck KGaA, Takeda Ph

06-23-2021 09:04 AM CET | Health & Medicine

Press release from: The Insight Partners

/ PR Agency: The Insight Partners
Angiotensin Converting Enzyme Inhibitors Market

Angiotensin Converting Enzyme Inhibitors Market

An off-the-shelf report on Angiotensin Converting Enzyme Inhibitors Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade journals, technical white papers, paid databases etc. followed by primary research (interviews) with industry experts/KOLs to gain their insights and views on current scenarios and future scope of the market as well as validating the secondary information, further internal statistical model is used to estimate the market size and forecasts till 2028.

Angiotensin converting enzyme inhibitors are a class of drugs used to treat heart failure, high blood pressure (hypertension), or lower complications of myocardial infarction (heart attack). These drugs are also helpful in lowering kidney disorders progression in patients with chronic kidney disease or kidney disease in diabetic patients. The process of angiotensin converting enzyme inhibitors is to reduce the amount of angiotensin II produced. Angiotensin II affects the body to increase pressure in the kidney, blood volume, and blood pressure. Angiotensin converting enzyme inhibitors open the blood vessels by lowering the amount of angiotensin II in the body. These also raise the amount of urine produced by kidneys. This results in reducing pressure in the kidney, lowering blood volume, and blood pressure.

Get sample PDF copy at: https://www.theinsightpartners.com/sample/TIPRE00023189/?source=openpr-10271

The key players influencing the market are:

Pfizer, Inc.
AstraZeneca Pharmaceutical Company
Novartis AG
Daiichi Sankyo Company, Ltd.
United Therapeutics Corporation
Sanofi S.A.
Johnson & Johnson Services, Inc.
Merck KGaA
Takeda Pharmaceutical Company
Bayer AG

This report contains:

• Market sizing for the global Angiotensin Converting Enzyme Inhibitors Market.
• Compare major Angiotensin Converting Enzyme Inhibitors Market providers strategies and approaches to the challenges they face
• Analysis of the effects deglobalisation trends may have for Angiotensin Converting Enzyme Inhibitors Market providers
• Profiles of major Angiotensin Converting Enzyme Inhibitors Market providers
• 7-year CAGR forecasts for Angiotensin Converting Enzyme Inhibitors Market -intensive vertical sectors

Angiotensin Converting Enzyme Inhibitors Market- Global Analysis to 2028 is an expert compiled study which provides a holistic view of the market covering current trends and future scope with respect to product/service, the report also covers competitive analysis to understand the presence of key vendors in the companies by analyzing their product/services, key financial facts, details SWOT analysis and key development in last three years. Further chapter such as industry landscape and competitive landscape provides the reader with recent company level insights covering mergers and acquisitions, joint ventures, collaborations, new product developments/strategies taking place across the ecosystem. The chapters also evaluate the key vendors by mapping all the relevant products and services to exhibit the ranking/ position of top 5 key vendors.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Angiotensin converting enzyme inhibitors market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

Angiotensin Converting Enzyme Inhibitors Market is a combination of qualitative as well as quantitative analysis which can be broken down into 40% and 60% respectively. Market estimation and forecasts are presented in the report for the overall global market from 2021 – 2028, considering 2018 as the base year and 2021 – 2028 forecast period. Global estimation is further broken down by segments and geographies such as North America, Europe, Asia-Pacific, Middle East & Africa and South America covering major 16 countries across the mentioned regions. The qualitative contents for geographical analysis will cover market trends in each region and country which includes highlights of the key players operating in the respective region/country, PEST analysis of each region which includes political, economic, social and technological factors influencing the growth of the market.

Key Benefits
 This report provides a detailed study of Angiotensin Converting Enzyme Inhibitors Market trends and forecast from 2021 to 2028, which assist to identify the prevailing market opportunities.
 In-depth coverage of the global Angiotensin Converting Enzyme Inhibitors market that includes drivers, restraints, and opportunities, helps professionals to understand the market behavior in a better way.
 This study further includes market analysis in terms of type and applications.
 Detailed study of the strategies of key leaders, partnerships, and acquisitions in the Angiotensin Converting Enzyme Inhibitors Market is provided.

Purchase This Report @ https://www.theinsightpartners.com/buy/TIPRE00023189/?source=openpr-10271

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Angiotensin Converting Enzyme Inhibitors Market With Top Key Players like Pfizer, AstraZeneca Pharmaceutical Company, Novartis AG, Daiichi Sankyo Company, Ltd. United Therapeutics Corporation, Sanofi S.A., Johnson & Johnson Services, Merck KGaA, Takeda Ph here

News-ID: 2311530 • Views:

More Releases from The Insight Partners

Insect Pest Control - Obtain PDF Sample Copy
The Insect Pest Control Market size is projected to reach US$ 14.85 billion by 2031 from US$ 21.33 billion in 2024. The market is expected to register a CAGR of 5.4% during 2025-2031. The proactive health measures, combined with heightened consumer awareness about disease prevention, have boosted the demand for both professional pest control services and DIY products. The convergence of public health policies, regulatory vigilance, and increased risk perception
Denim Fabrics - Obtain PDF Sample Copy
The denim fabrics market size is projected to reach US$ 28.69 billion by 2031 from US$ 22.32 billion in 2024. The market is expected to register a CAGR of 3.8% during 2025-2031. The denim fabrics market is growing steadily owing to changing consumer preferences, fashion trends, and increasing accessibility. Denim has evolved from being a utilitarian fabric to a mainstream fashion item, appreciated for its flexibility, comfort, and ease. With
Photomedicine Devices and Technologies Market Global Rising Demand & Huge Scope Till 2028
Photomedicine Devices and Technologies Market Global Rising Demand & Huge Scope …
A new market study report by The Insight Partners on the Photomedicine Devices and Technologies Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. Get PDF Sample
Genetic Testing Services Market Global Rising Demand & Huge Scope Till 2031
Genetic Testing Services Market Global Rising Demand & Huge Scope Till 2031
Genetic Testing Services Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market

All 5 Releases


More Releases for Angiotensin

Innovative Product Solution In The Angiotensin Receptor Blockers Market Industry …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Angiotensin Receptor Blockers (ARBs) Market Size Valuation Forecast: What Will the Market Be Worth by 2025? Growth has been consistently noted in the angiotensin receptor blockers (arbs) market size in the past few years. The market will see an increase from $8.51 billion in 2024 to $8.78 billion in
Angiotensin Converting Enzyme (ACE) Inhibitors Market
Angiotensin Converting Enzyme (ACE) inhibitors are a class of pharmaceutical drugs used primarily for the treatment of high blood pressure (hypertension), heart failure, and chronic kidney diseases. These medications help to relax blood vessels, thereby lowering blood pressure and improving heart function. ACE inhibitors block the activity of the enzyme that converts angiotensin I to angiotensin II, a peptide that narrows blood vessels. By inhibiting this conversion, ACE inhibitors enable
Angiotensin Converting Enzyme (ACE) Inhibitors Market: An Overview
Angiotensin Converting Enzyme (ACE) inhibitors are a class of medications widely used in the treatment of various cardiovascular conditions, primarily high blood pressure (hypertension) and heart failure. These drugs work by blocking the action of the enzyme angiotensin-converting enzyme, which is responsible for producing a substance called angiotensin II. Angiotensin II constricts blood vessels and raises blood pressure. By inhibiting this enzyme, ACE inhibitors help relax blood vessels, lower blood
Prominent Angiotensin Receptor Blockers (ARBs) Market Trend for 2025: Innovative …
What market dynamics are playing a key role in accelerating the growth of the angiotensin receptor blockers (arbs) market? The upward trend of cardiovascular diseases is predicted to fuel advancements in the angiotensin receptor blockers market. Often related to the accumulation of fatty components within the arteries (atherosclerosis) and heightened probability of blood clots, cardiovascular disease (CVD) influences the heart or blood vessels. The function of angiotensin receptor blockers is to
Angiotensin Receptor Blockers (ARBs) Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Angiotensin Receptor Blockers (ARBs) Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. The Angiotensin Receptor Blockers (ARBs) market has been expanding steadily due to their widespread use in the treatment of hypertension, heart failure, and
Angiotensin Receptor Blockers (ARBs) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Angiotensin Receptor Blockers (ARBs) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report